KYOWA KIRIN CO. LTD.

Analyst Reco. Kyowa Kirin Co. Ltd.

Equities

4151

JP3256000005

Delayed Japan Exchange Other stock markets 02:00:00 2024-05-02 am EDT			5-day change	1st Jan Change
2,668 ^JPY	0.00%		+0.45%	+12.55%

May. 02	BridgeBio Pharma Shares Decline After Q1 Financial Results	MT
Apr. 08	U.S. FDA declines to approve Supernus' drug-device combination for Parkinson's disease	RE

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Jefferies Adjusts Kyowa Kirin’s Price Target to 3,000 Yen From 3,600 Yen, Keeps at Buy	23-10-09	MT
Jefferies Adjusts Kyowa Kirin's Price Target to 3,600 Yen From 3,900 Yen, Keeps at Buy	23-03-30	MT
Nikkei 225 Down 1.5% on ECB Rate Hike, US CPI Outlook	22-06-10	MT
MEI Pharma Says Treatment With Follicular Lymphoma Drug Candidate Shows Complete Response Rate of Over 35% in Mid-Stage Trial	21-11-30	MT
Kyowa Hakko Kirin Co., Ltd. Provides Tax Rate Outlook for the Year 2018	18-02-08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

As early as today, start finding the best investment opportunities!

Optimize my profits

fermer